This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Knowing when to opt for index funds over stocks helps you prioritize diversification and lower maintenance while pursuing gains.
25,835 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Choosing between Salesforce and Braze in 2026 requires weighing scale, revenue mix, and growth prospects. This guide ...
NVIDIA has slipped about 17% from its May high, leaving investors debating whether the AI powerhouse is finally a bar...
If you’re weighing Peloton as an investment, you’re not alone. This piece lays out two essential reasons I haven’t bo...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...
The U.S. copper market, a roughly $20 billion arena, is flashing a breakout signal as cash costs go negative and by-p...
Policy makers and tech leaders converge to treat China as a shared risk in AI leadership, signaling potential shifts ...
Fed Chair Kevin Warsh grapples with President Trump's pressure to slash rates, a stance that could influence Social S...
Cerebras stock is climbing as fresh news and growing AI demand spark investor excitement. This guide breaks down the ...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
IBM argues that data gravity keeps information in place. This investing piece explains why that matters, how AI reinf...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...